Theranos Documentary Fuels 186% Surge in The Dropout Viewership 2026

The Theranos documentary You Can See Everything has ignited a 186% surge in viewership for The Dropout, the 2022 Hulu series about Elizabeth Holmes, according to Variety. The spike follows the release of the film's first teaser on September 6, highlighting renewed public fascination with the disgraced CEO and her fraudulent blood-testing company.

Interest in Holmes and the Theranos scandal has skyrocketed, with viewership nearly doubling again during the week of October 12—up 92% from the prior week—just before the film's October 16 premiere. The phenomenon extends beyond streaming: John Carreyrou's 2018 book Bad Blood, which exposed the fraud, has returned to the New York Times bestseller list.

Why the Theranos Documentary Is Driving Viewership

The three-hour film, produced by A24 and directed by Nathan Fielder and Lance Oppenheim, opened to an extraordinary $15 million in North America on just 855 screens. That marks the best opening weekend for a documentary in more than two decades, since Michael Moore's Fahrenheit 9/11 in 2004.

The massive debut suggests a cultural appetite for the Theranos saga that refuses to fade. As audiences flock to theaters, they're also turning to related content—like The Dropout—to deepen their understanding of the scandal.

The Amanda Seyfried Effect

Amanda Seyfried's portrayal of Holmes in The Dropout earned critical acclaim, including an Emmy Award. The series dramatizes Holmes's rise and fall, from her days as a Stanford dropout to becoming the youngest female self-made billionaire, with a net worth of $4.5 billion by age 30.

The renewed interest in the series underscores how true-crime dramas can experience second lives when new documentaries or news events thrust their subjects back into the spotlight.

The Rise and Fall of Elizabeth Holmes

Holmes founded Theranos in 2003, promising to revolutionize blood testing with technology that could run hundreds of tests from a single drop of blood. The company attracted high-profile investors and partners, including Walgreens, and Holmes became a media darling.

But in 2015, Carreyrou's reporting in The Wall Street Journal revealed that Theranos's devices were flawed and could not accurately test blood samples. Holmes and others knew about these issues, leading to the company's collapse in 2018. Holmes was later convicted of fraud and sentenced to prison.

Key Figures in the Theranos Saga

• Elizabeth Holmes: Founder and CEO, convicted of wire fraud and conspiracy.
• Ramesh "Sunny" Balwani: Former COO and Holmes's ex-boyfriend, also convicted of fraud.
• John Carreyrou: Investigative journalist who exposed the fraud in Bad Blood.
• Tyler Shultz and Erika Cheung: Whistleblowers who raised concerns about Theranos's technology.
• David Boies: Attorney who represented Theranos and Holmes.

Comparing Theranos Media: Documentary vs. Drama Series

The table illustrates how different media formats have tackled the Theranos story, each offering unique perspectives. The latest documentary's success suggests that audiences are hungry for fresh takes on the scandal, even years after the company's demise.

What the Viewership Surge Means for True Crime Content

The 186% jump in The Dropout viewership demonstrates the powerful synergy between new releases and existing content. When a high-profile documentary like You Can See Everything hits theaters, it often drives audiences to explore related series, books, and articles.

Streaming platforms benefit from this halo effect, as viewers binge-watch dramatized versions of the stories they've just seen on the big screen. This cross-pollination of interest can revive older content and introduce it to new audiences.

For content creators, the lesson is clear: the appetite for compelling true-crime narratives remains strong, especially when a new project reignites public curiosity. The Theranos saga, with its blend of ambition, deception, and downfall, continues to captivate audiences across multiple mediums. The background to this story is set out in Celebrity: latest articles.

FAQ